A new review highlights how advances in DNA technology are reshaping the future of healthcare by shifting the focus from treatment to prevention. Cutting-edge tools are enabling earlier detection of risk and more precise intervention at the genetic level, offering the potential to stop diseases before symptoms ever appear.
Central to this transformation is CRISPR-Cas9 gene editing, a powerful method that allows scientists to correct defective genes with remarkable accuracy. This approach is opening new possibilities for preventing inherited conditions such as cystic fibrosis and sickle cell disorders, while also contributing to innovations in cancer prevention and immune system enhancement.
Alongside gene editing, advances in epigenetic modification are revealing how environmental and lifestyle factors influence gene activity. By targeting these reversible changes, new strategies are emerging to reduce the risk of chronic illnesses, including cancer and metabolic disorders. This marks a significant evolution in understanding how gene expression can be managed without altering the DNA sequence itself.
The review also emphasizes the importance of RNA-based therapies, which are rapidly gaining momentum as tools for regulating gene activity and preventing disease progression. Technologies such as mRNA platforms have already demonstrated their value in public health and are now being adapted for broader applications, including cancer prevention and rare genetic conditions.
Another promising avenue is somatic cell genome editing, which targets non-reproductive cells to correct genetic abnormalities without affecting future generations. This approach provides a practical and ethically viable pathway for applying gene editing in clinical settings, reducing concerns associated with heritable genetic changes.
In addition, innovations such as next-generation sequencing, synthetic biology, and AI-driven genome analysis are enhancing the ability to identify disease risk early and tailor interventions to individual genetic profiles. These technologies are driving the shift toward personalized medicine, where prevention strategies are designed around each person’s unique biology.
Despite the promise, challenges remain, including ensuring safety, improving delivery methods, and addressing ethical considerations. However, the continued evolution of these technologies signals a future where healthcare is increasingly predictive, personalized, and proactive.
Together, these advancements underscore a transformative moment in medicine, where mastering the molecular foundations of life is enabling a new era of disease prevention with far-reaching global impact.
# # # # # #
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 10.4 |Impact Factor:14.6
# # # # # #
More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available online in ScienceDirect (https://www.sciencedirect.com/journal/genes-and-diseases).
Submissions to Genes & Diseases may be made using Editorial Manager (https://www.editorialmanager.com/gendis/default.aspx).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.cn
X (formerly twitter): @GenesNDiseases (https://x.com/GenesNDiseases)
# # # # # #
Reference
Giri Rajasekhar Dornadula, Ramakrishna Chilakala, Sadak Basha Shaik, Pramod Kumar Meriga, Likhitha Chintha, Yeshwanth Gurugari, Kranthi Kumar D, Sameena Fatima Shaik, Sun Hee Cheong, Molecular mastery: Harnessing DNA technology for disease prevention, Genes & Diseases, Volume 13, Issue 4, 2026, 101976, https://doi.org/10.1016/j.gendis.2025.101976

Funding
University Industry Liaison of Chonnam National University 2025-0929
Ministry of Education (MOE) and the Jeollanamdo, Republic of Korea 2025-RISE-14-007